View of Single-injection intravitreal bevacizumab versus bevacizumab–triamcinolone for diabetic macular edema: a prospective comparative observational study evaluating efficacy, durability and intraocular pressure safety during 12 weeks of follow-up.

Return to Article Details Single-injection intravitreal bevacizumab versus bevacizumab–triamcinolone for diabetic macular edema: a prospective comparative observational study evaluating efficacy, durability and intraocular pressure safety during 12 weeks of follow-up. Download Download PDF